Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:affiliatedWith |
gptkb:coumarins
|
| gptkbp:CASNumber |
5543-58-8
|
| gptkbp:chirality |
S-enantiomer
|
| gptkbp:drugClass |
gptkb:anticoagulant
|
| gptkbp:has_stereochemistry |
S
|
| gptkbp:hasMolecularFormula |
C19H16O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
S-warfarin
|
| gptkbp:isomerOf |
gptkb:warfarin
|
| gptkbp:IUPACName |
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
|
| gptkbp:mechanismOfAction |
vitamin K epoxide reductase inhibitor
|
| gptkbp:metabolism |
gptkb:CYP2C9
|
| gptkbp:molecularWeight |
308.33 g/mol
|
| gptkbp:more_potent_than |
gptkb:R-warfarin
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1201202
54678486 CHEBI:10033 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:UNII |
8VZV102F5D
|
| gptkbp:usedFor |
prevention of thrombosis
|
| gptkbp:bfsParent |
gptkb:CYP2C9
|
| gptkbp:bfsLayer |
5
|